Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call

PGNY or CRL: Which Is the Better Value Stock Right Now?

Charles River Gains 75.8% in a Year: What's Driving the Rally?

Charles River and Autolomous Partner to Transform Laboratory Execution Systems

Charles River Laboratories International, Inc. (NYSE:CRL) Stock Has Consensus Price Target of $290.00 According to Analysts

Charles River Targets 5%-7% Growth, $300M Savings in 2030 Plan

Charles River Laboratories International, Inc. (CRL) Analyst/Investor Day Transcript

Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day

Financial Comparison: Charles River Laboratories International (NYSE:CRL) versus Adaptive Biotechnologies (NASDAQ:ADPT)

PGNY vs. CRL: Which Stock Is the Better Value Option?

Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines

Charles River Laboratories International, Inc. (CRL) Presents at 2026 Global Healthcare Conference Transcript

Charles River Laboratories International, Inc. (CRL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Charles River Laboratories to Present at Morgan Stanley and Baird Conferences

Charles River Laboratories to Present at Morgan Stanley and Baird Conferences

Amundi Sells 360,913 Shares of Charles River Laboratories International, Inc. $CRL

Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund?

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?

Is This the Right Time to Add CRL Stock to Your Portfolio?